Oncology MRI

Catch up on the top radiology news of the past week.

New research suggests the capability of a mammography-based deep learning model to identify women at high risk of breast cancer led to more than triple the cancer detection rate on breast MRI in comparison to traditional risk assessment tools.

A robotic guidance and placement system, the IGAR system can be utilized inside of a magnetic resonance imaging (MRI) bore.

Catch up on the top radiology content of the past week.

Through the use of artificial intelligence (AI) and imaging modalities such as ultrasound, CT, and MRI, the newly FDA-cleared VisAble.IO software reportedly enhances planning and real-time assessment for liver tumor ablation procedures.

Catch up on the top radiology content of the past week.

Wayne G. Brisbane, MD, of the University of California, Los Angeles, discussed the challenges of focal therapy for prostate cancer and how Unfold AI can help improve the accuracy of this treatment, as well as help counsel patients during the treatment decision process.

Catch up on the top five most viewed content at Diagnostic Imaging in August 2023.

Catch up on the top AI-related news and research from the past month.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

In a new study comparing standard breast MRI, abbreviated breast MRI and contrast-enhanced mammography in supplemental breast cancer screening, researchers found that MRI offered a greater than 14 percent higher cancer detection rate and a nearly 39 percent higher sensitivity rate than CEM.

Catch up on the top radiology content of the past week.

Emerging research suggests that a high volume of enhancing parenchyma on dynamic contrast-enhanced MRI more than doubles the breast cancer risk for women with extremely dense breasts.

The indications for Gadobutrol injection, a generic substitute for Gadavist, include neurovascular and cardiovascular assessments as well as breast malignancy detection with magnetic resonance imaging (MRI).

Catch up on the top radiology content of the past week.

Catch up on the top radiology news of the past week.

Newly published research suggests the use of gadopiclenol at 0.05 mmol/kg is non-inferior to gadobutrol 0.1 mmol/kg for all qualitative visualization parameters on full-body magnetic resonance imaging (MRI).

Catch up on the top radiology content of the past week.

Superfluous pan scans have become standard for a vast majority of minor injury presentations in emergency room settings.

Catch up on the top AI-related news and research from the past month.

Catch up on the top radiology content of the past week.

For patients with residual or recurrent grade 2 isocitrate dehydrogenase (IDH)-mutant gliomas, magnetic resonance imaging (MRI) revealed that daily dosing of vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes, led to a median progression-free survival of 27.7 months in comparison to 11.1 months in a placebo group, according to new research presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Catch up on the top radiology content of the past week.

The combination of Philips’ MR 7700 multi-nuclei scanner with the FDA-approved Xenoview hyperpolarized Xenon magnetic resonance imaging (MRI) contrast agent may facilitate earlier diagnosis and intervention for patients with obstructive lung diseases.

The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI.

Conditional use of full-body magnetic resonance imaging (MRI) is reportedly permitted for patients using any of the models for the remede® System, an implantable nerve stimulation therapy indicated for the treatment of adults with moderate to severe central sleep apnea.

Catch up on the top AI-related news and research from the past month.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.